Buyout Firm CBC, Mubadala Lead Hasten’s $315 Million Fundraising
Chinese drugmaker Hasten Biopharmaceutic Co. has raised $315 million in a new funding round, led by CBC Group, an Asian health-care focused investment firm, and Abu Dhabi’s Mubadala Investment Co.









